Stereotactic Body Radiation Therapy (SBRT) for Recurrent Non-small Cell Lung Cancer (NSCLC)

Medicine and Dentistry

• Non Small Cell Lung Cancer 100%
• Stereotactic Body Radiation Therapy 100%
• Low Drug Dose 40%
• Recurrent Disease 20%
• Drug Megadose 20%
• Tissue Injury 20%
• Distant Metastasis 20%
• Survival Rate 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Small Cell Lung Cancer 100%
• Recurrent Disease 33%
• Tissue Injury 33%
• Distant Metastasis 33%
• Survival Rate 33%